Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 324-329 , February 2011

More Than Meets the Eye

  • Rebecca L. Manno, MD
    • ,
  • Stuart M. Levine, MD
    • ,
  • Allan C. Gelber, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Allan C. Gelber, MD, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Baltimore, MD 21224

References 

  1. Jakob E, Reuland MS, Mackensen F, Harsch N, Fleckenstein M, Lorenz HM, et al. Uveitis subtypes in a German interdisciplinary uveitis center—analysis of 1916 patients. J Rheumatol. 2009;36(1):127–136
  2. Thorne JE, Jabs DA. The eye in rheumatic disease. In:  Hochberg MC,  Silman AJ,  Smolen JS,  Weinblatt ME,  Weisman MH editor. Rheumatology. 4th ed.. Philadelphia (PA): Elsevier; 2008;p. 261–268
  3. Rosenbaum JT. An algorithm for the systemic evaluation of patients with uveitis: Guidelines for the consultant. Semin Arthritis Rheum. 1990;19(4):248–257
  4. Kiss S, Damico FM, Young LH. Ocular manifestations and treatment of syphilis. Semin Ophthalmol. 2005;20(3):161–167
  5. Roberts WC, Ko JM, Vowels TJ. Natural history of syphilitic aortitis. Am J Cardiol. 2009;104(11):1578–1587
  6. Centers for Disease Control and Prevention. Sexually transmitted diseases surveillance 2006, national profile. [homepage on the Internet] Atlanta (GA): U.S. Department of Health and Human Services; 2006;http://www.cdc.gov/std/stats06/syphilis.htm
  7. Wegener F. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. Beitr Pathol Anat Allg Pathol. 1939;102:30–68[in German]
  8. Weiler V, Redtenbacher S, Bancher C, Fischer MB, Smolen JS. Concurrence of sarcoidosis and aortitis: Case report and review of the literature. Ann Rheum Dis. 2000;59(11):850–853
  9. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med. 1994;120(11):919–929
  10. Yilmaz S, Aydemir E, Maden A, Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colorectal Dis. 2007;22(9):1027–1030
  11. Talbot RW, Heppell J, Dozois RR, Beart RW. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61(2):140–145
  12. Reny JL, Paul JF, Lefebvre C, Champion K, Emmerich J, Bletry O, et al. Association of Takayasu's arteritis and Crohn's disease (Results of a study on 44 Takayasu patients and review of the literature). Ann Med Interne (Paris). 2003;154(2):85–90
  13. Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG. Takayasu arteritis (A study of 32 North American patients). Medicine (Baltimore). 1985;64(2):89–99
  14. Todini AR, Heinzmann MM, Antignani PL, Paiella ML. Association between Takayasu's arteritis and Crohn's disease in two young women: Case reports. J Mal Vasc. 1999;24(5):373–376
  15. Yazdanyar S, Weischer M, Nordestgaard BG. Genotyping for NOD2 genetic variants and Crohn disease: A metaanalysis. Clin Chem. 2009;55(11):1950–1957
  16. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603–606
  17. Levine SM, Racusen L, Gelber AC. Seeing red. Am J Med. 2006;119(2):123–124
  18. Haynes BF, Fishman ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis (Fifteen years experience and review of the literature). Am J Med. 1977;63(1):131–141
  19. Chirinos JA, Tamariz LJ, Lopes G, Del Carpio F, Zhang X, Milikowski C, et al. Large vessel involvement in ANCA-associated vasculitides: Report of a case and review of the literature. Clin Rheumatol. 2004;23(2):152–159
  20. Nakabayashi K, Kamiya Y, Nagasawa T. Aortitis syndrome associated with positive perinuclear antineutrophil cytoplasmic antibody: Report of three cases. Int J Cardiol. 2000;75(Suppl 1):S89–S94discussion S95-7
  21. Sieber SC, Cuello B, Gelfman NA, Garfinkel HB. Pulmonary capillaritis and glomerulonephritis in an antineutrophil cytoplasmic antibody-positive patient with prior granulomatous aortitis. Arch Pathol Lab Med. 1990;114(12):1223–1226
  22. Blockmans D, Baeyens H, Van Loon R, Lauwers G, Bobbaers H. Periaortitis and aortic dissection due to Wegener's granulomatosis. Clin Rheumatol. 2000;19(2):161–164
  23. Gelber AC. Classification and epidemiology of inflammatory vascular disease. In:  Hochberg MC,  Silman AJ,  Smolen JS,  Weinblatt ME,  Weisman MH editor. Rheumatology. 4th ed.. Philadelphia (PA): Elsevier; 2008;p. 1489–1498
  24. Takayasu M. A case with peculiar lesions of the retinal central vessels. Acta Soc Opthal Jpn. 1908;(12):554–555
  25. Shimizu K, Sano K. Pulseless disease. J Neuropathol Clin Neurol. 1951;1:37–57
  26. Ureten K, Ozturk MA, Onat AM, Ozturk MH, Ozbalkan Z, Guvener M, et al. Takayasu's arteritis: Results of a university hospital of 45 patients in Turkey. Int J Cardiol. 2004;96(2):259–264
  27. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: Clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26(3 Suppl 49):S9–S15
  28. Kausman JY, Walker A, Piper S. Acute panuveitis and Takayasu's arteritis. Arch Dis Child. 2003;88(10):938–939
  29. Jolly M, Curran JJ. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis. J Clin Rheumatol. 2005;11(4):213–215
  30. Kaliaperumal S, Gupta A, Sengupta S, Srinivasan R. Unilateral hemorrhagic keratouveitis as the initial presentation of Takayasu's arteritis. Indian J Ophthalmol. 2007;55(5):397–398
  31. Becker RW, Sohn RL, Poulik JM, Berguer R. Takayasu's arteritis presenting as uveitis in a 5-year-old girl. Ann Vasc Surg. 2005;19(2):258–262
  32. McDonald MA, Ojaimi E, Favilla I. Anterior uveitis in a child with Takayasu's arteritis. Clin Exp Ophthalmol. 2004;32(3):336–339
  33. Maksimowicz-McKinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000–1009
  34. Wagner AD, Andresen J, Raum E, Lotz J, Zeidler H, Kuipers JG, et al. Standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis. Ann Rheum Dis. 2005;64(1):105–110
  35. Daniel E, Thorne JE, Newcomb CW, Pujari SS, Kacmaz RO, Levy-Clarke GA, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. 2010;149(3):423;32.e1-2.
  36. Shinjo SK, Pereira RM, Tizziani VA, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol. 2007;26(11):1871–1875
  37. Daina E, Schieppati A, Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: Report of three cases. Ann Intern Med. 1999;130(5):422–426
  38. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50(7):2296–2304
  39. Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: Long-term follow-up. Ann Rheum Dis. 2008;67(11):1567–1569

PII: S0049-0172(10)00050-8

doi: 10.1016/j.semarthrit.2010.03.004

Seminars in Arthritis and Rheumatism
Volume 40, Issue 4 , Pages 324-329 , February 2011

Article Tools

* Image Usage & Resolution